198 related articles for article (PubMed ID: 32451980)
1. Insulin resistance, androgens, and lipids are gradually improved in an age-dependent manner in lean women with polycystic ovary syndrome: insights from a large Caucasian cohort.
Livadas S; Macut D; Bothou C; Kuliczkowska-Płaksej J; Vryonidou A; Bjekic-Macut J; Mouslech Z; Milewicz A; Panidis D
Hormones (Athens); 2020 Dec; 19(4):531-539. PubMed ID: 32451980
[TBL] [Abstract][Full Text] [Related]
2. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
[TBL] [Abstract][Full Text] [Related]
3. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
Anik Ilhan G; Yildizhan B; Pekin T
Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
[TBL] [Abstract][Full Text] [Related]
4. Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population.
Glueck CJ; Morrison JA; Goldenberg N; Wang P
Metabolism; 2009 May; 58(5):714-21. PubMed ID: 19375597
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
6. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).
Daghestani MH; Daghestani M; Daghistani M; El-Mazny A; Bjørklund G; Chirumbolo S; Al Saggaf SH; Warsy A
Lipids Health Dis; 2018 Aug; 17(1):195. PubMed ID: 30131073
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
8. Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome.
Remsberg KE; Talbott EO; Zborowski JV; Evans RW; McHugh-Pemu K
Fertil Steril; 2002 Sep; 78(3):479-86. PubMed ID: 12215321
[TBL] [Abstract][Full Text] [Related]
9. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
10. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
Karadağ C; Yoldemir T
J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
[TBL] [Abstract][Full Text] [Related]
11. Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause.
Markopoulos MC; Valsamakis G; Kouskouni E; Boutsiadis A; Papassotiriou I; Creatsas G; Mastorakos G
Eur J Endocrinol; 2013 Jan; 168(1):83-90. PubMed ID: 23076844
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profile in women with polycystic ovary syndrome across adult life.
Echiburú B; Crisosto N; Maliqueo M; Pérez-Bravo F; de Guevara AL; Hernández P; Cavada G; Rivas C; Clavel A; Sir-Petermann T
Metabolism; 2016 May; 65(5):776-782. PubMed ID: 27085784
[TBL] [Abstract][Full Text] [Related]
13. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
14. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
15. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
Ezeh U; Pall M; Mathur R; Azziz R
Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
[TBL] [Abstract][Full Text] [Related]
16. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
17. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
[TBL] [Abstract][Full Text] [Related]
18. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
[TBL] [Abstract][Full Text] [Related]
19. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
20. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome.
Yilmaz MA; Duran C; Basaran M
J Endocrinol Invest; 2016 Jan; 39(1):45-53. PubMed ID: 26100531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
